Advertisement

CROI 2010 Newsroom: Transmission/Epidemiology
- Future of AIDS Gels May Lie in Drugs, Experts Say (March 8, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- HIV Vaccine Trial Lessons: What Researchers Learned From the STEP Study's Failure and the RV144 ("Thai") Study's Success (March 3, 2010)
A discussion with Nelson Michael, M.D., Ph.D., and Morgane Rolland, Ph.D.
In The 17th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Why There's Such an HIV/AIDS Disparity Among U.S. Blacks and Hispanics -- and What to Do About It (February 24, 2010)
A discussion with Kimberly Smith, M.D., M.P.H.
In The 17th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- ART Improves Cerebral Blood Flow -- but Not to Levels in HIV-Negatives (February 23, 2010)
From National AIDS Treatment Advocacy Project
- Many Patients Diagnosed With HIV Today Will Have Normal Life Expectancies, European Studies Find (February 22, 2010)
From aidsmap.com
- News Outlets Examine Use of ART, Microbicide Development Presented at Conference (February 22, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Life Expectancy Approaches Normal in Dutch Without HIV Symptoms (February 20, 2010)
From National AIDS Treatment Advocacy Project
- Three Years With More Than 500 CD4s Normalizes Mortality in HIV-Positive Men (February 20, 2010)
From National AIDS Treatment Advocacy Project
- Hepatitis C Virus Can Survive in Syringes for Up to 63 Days (February 20, 2010)
From aidsmap.com
- HIV Treatment May Prevent at Least Nine Out of Ten Transmissions (February 19, 2010)
From aidsmap.com
- AIDS Vaccine Effects May Wear Off, Researchers Say (February 19, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- News Outlets Examine HIV Vaccine Research, Cervical Cancer Screening Data Presented at Conference (February 19, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Treatment Drive in British Columbia Produces Modest Declines in Diagnoses and Viral Loads (February 19, 2010)
From aidsmap.com
- Maraviroc Showing Tantalising Promise as Microbicide in Preclinical Studies (February 19, 2010)
From aidsmap.com
- Side Effect and CD4 Differences in Four ACTG 5202 Arms at 96 Weeks (February 18, 2010)
From National AIDS Treatment Advocacy Project
- HIV Drugs Prevent Infection in African Study (February 18, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- French Gay Men Face Sixtyfold HIV Risk: Incidence Increasing in Netherlands (February 18, 2010)
From aidsmap.com
- Increased Testing Leads to Decrease in Viral Load and Infections in San Francisco, and in Late Diagnosis in Washington (February 18, 2010)
From aidsmap.com
- Studies Show Long-Term Couples Overlooked by HIV Prevention Strategies (February 18, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- The New Quad on the Block: Gilead's Four-Drug, Fixed-Dose Combination With a Novel Booster Sails Through Phase 2 Trials (Feb. 18, 2010; 1:15 a.m. Pacific Time)
A blog entry from CROI 2010 by Myles Helfand.
In The 17th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Will CROI 2010 Provide HIV/AIDS Clinicians With More Questions Than Answers? (Feb. 16, 2010; 4:49 p.m. Pacific Time)
A blog entry from CROI 2010 by Myles Helfand.
In The 17th Conference on Retroviruses and Opportunistic Infections, from The Body PRO